Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

被引：4
|
作者：
Kamal, Mohamed A. [1 ]
Ganguly, Samit [1 ]
Kadambi, Ananth [2 ]
Smith, Patrick F. [2 ]
机构：
[1] Regeneron Pharmaceut, Tarrytown, NY 10591 USA
[2] Certara, Princeton, NJ 08540 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 116卷 / 03期
关键词：
D O I：
10.1002/cpt.3357
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：518 / 521
页数：4
相关论文
共 50 条
  • [1] Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan
    Sasaki, Tomohiro
    JPMA MIDD Task Force, Tomohiro
    Katsube, Takayuki
    Hayato, Seiichi
    Yamaguchi, Shingo
    Tanaka, Jun
    Yoshimatsu, Hiroki
    Nakanishi, Yushi
    Kitamura, Atsushi
    Watase, Hirotaka
    Suganami, Hideki
    Matsuoka, Nobushige
    Hasegawa, Chihiro
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2025, 52 (01)
  • [2] Model-Informed Drug Development: A Regulatory Perspective on Progress
    Zhu, Hao
    Huang, Shiew Mei
    Madabushi, Rajanikanth
    Strauss, David G.
    Wang, Yaning
    Zineh, Issam
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 91 - 93
  • [3] Cases studies of application of model-informed drug development in early phase clinical trials
    ZHAO Wei
    中国药理学与毒理学杂志, 2023, 37(S1) (S1) : 39 - 40
  • [4] Role of Model-Informed Drug Development in Pediatric Drug Development, Regulatory Evaluation, and Labeling
    Bi, Youwei
    Liu, Jiang
    Li, Lingjue
    Yu, Jingyu
    Bhattaram, Atul
    Bewernitz, Michael
    Li, Ruo-jing
    Liu, Chao
    Earp, Justin
    Ma, Lian
    Zhuang, Luning
    Yang, Yuching
    Zhang, Xinyuan
    Zhu, Hao
    Wang, Yaning
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 : S104 - S111
  • [5] Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective
    Youwei Bi
    Jiang Liu
    Jie Wang
    Roselyn E. Epps
    David Kettl
    Kendall Marcus
    Shirley Seo
    Hao Zhu
    Yaning Wang
    The AAPS Journal, 21
  • [6] Perspective on model-informed drug development
    Lesko, Lawrence J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (10): : 1127 - 1129
  • [7] Reflections on Model-Informed Drug Development
    Lesko, Lawrence J.
    van der Graaf, Piet H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (02) : 267 - 270
  • [8] Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective
    Bi, Youwei
    Liu, Jiang
    Wang, Jie
    Epps, Roselyn E.
    Kettl, David
    Marcus, Kendall
    Seo, Shirley
    Zhu, Hao
    Wang, Yaning
    AAPS JOURNAL, 2019, 21 (05):
  • [9] Model-Informed Approaches to Support Drug Development for Patients With Obesity: A Regulatory Perspective
    Pan, Xiaolei
    Wang, Li
    Liu, Jiang
    Earp, Justin C.
    Yang, Yuching
    Yu, Jingyu
    Li, Fang
    Bi, Youwei
    Bhattaram, Atul
    Zhu, Hao
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 : S65 - S77
  • [10] Enhancing inclusivity in clinical trials: Model-informed drug development for pregnant individuals in the era of personalized medicine
    Dallmann, Andre
    Bonate, Peter L.
    Burnham, Janelle
    George, Blessy
    Yao, Lynne
    Knochel, Jane
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (11): : 1824 - 1829
12345